Biofrontera (BFRI) Competitor Comparison
We are evaluating the key criteria listed to compare Biofrontera (BFRI) against its competitors in the Drug Manufacturers - Specialty & Generic industry.
Market Capitalization
54 / 54Gross Profits
36 / 39Total Revenue
45 / 50EBITDA
42 / 53Free Cashflow
34 / 54Quick Ratio
51 / 54Earnings per Share
51 / 54Dividend yield
0 / 5Total Cash
51 / 54Performance 3 years
54 / 54Performance 5 years
53 / 54Performance 10 years
53 / 54Linearity 3 years
49 / 54Linearity 5 years
43 / 54Linearity 10 years
44 / 54Total Rank
53 / 54Dividend Rank
50 / 54Valuation Rank
51 / 54Piotroski Rank
54 / 54Muliplier Rank
36 / 54Market Capitalization - BFRI ranking 54 / 54
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.